ETON
ETON
US29772L1089
Eton Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.58B EUR
1.02B EUR
675.24M EUR
457.37M EUR
Enterprise Value
1.57B EUR
1.03B EUR
686.77M EUR
462.44M EUR
Valuation Multiples
Trailing P/E
138.03x
80.71x
--
--
Forward P/E
21.4x
--
--
--
Price to Sales
14.94x
9.7x
7.77x
7.3x
Price to Book
33.52x
21.98x
22.06x
17.49x
EV/Revenue
14.84x
9.72x
7.9x
7.38x
EV/EBITDA
62.25x
49.22x
110.73x
174.05x
Price to FCF (P/FCF)
239.78x
--
1,566.68x
56.46x
EV/FCF
238.15x
--
1,593.42x
57.08x
FCF Yield
0.42%
-0.03%
0.06%
1.77%
ende